He aha ʻo Tildrakizumab: Nā hoʻohana, ka nui, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau i kauoha ʻia ʻo Tildrakizumab e kōkua i ka mālama ʻana i ka psoriasis plaque waena a koʻikoʻi i nā pākeke. Hana kēia lāʻau lapaʻau injectable ma ka hoʻopaʻa ʻana i nā protein kikoʻī i loko o kāu ʻōnaehana pale e kōkua i nā hōʻailona psoriasis.

Inā ʻoe e hana nei me nā pā psoriasis e uhi ana i kahi ʻāpana nui o kou kino a i ʻole ʻaʻole i pane maikaʻi i nā lāʻau lapaʻau ʻē aʻe, hiki i kāu kauka ke ʻōlelo aku iā tildrakizumab ma ke ʻano he ʻāpana o kāu hoʻolālā lapaʻau. Ua hoʻolālā ʻia e kōkua i ka hoʻomaʻemaʻe ʻana i kou ʻili a hōʻemi i ka mumū e hana ai i kēlā mau pā ʻoluʻolu a me ka unahi.

He aha ʻo Tildrakizumab?

He ʻano lāʻau lapaʻau ʻo Tildrakizumab i kapa ʻia he monoclonal antibody e kuhikuhi pono ana i ka psoriasis. No ka papa o nā lāʻau lapaʻau i ʻike ʻia he biologics, i hana ʻia mai nā cell ola ma mua o nā kemika.

Hele mai kēia lāʻau lapaʻau ma ke ʻano he syringe i hoʻopiha mua ʻia a i ʻole peni āu e hoʻokomo ai ma lalo o kou ʻili (subcutaneously). ʻO ka inoa inoa no tildrakizumab ʻo Ilumya, a ua ʻae ʻia no ka mālama ʻana i ka psoriasis plaque waena a koʻikoʻi i nā pākeke i nā moho no ka therapy systemic a i ʻole phototherapy.

ʻAʻole like me nā ʻaila topical a i ʻole nā ​​pills, hana ʻo tildrakizumab mai loko mai o kou kino e hoʻoponopono i ke kumu kumu o ka mumū psoriasis. Manaʻo ʻia he therapy i manaʻo ʻia no ka mea e kālele ana i nā ala ʻōnaehana pale kikoʻī e pili ana i ka hoʻomohala ʻana i ka psoriasis.

No ke aha e hoʻohana ʻia ai ʻo Tildrakizumab?

Hoʻohana nui ʻia ʻo Tildrakizumab no ka mālama ʻana i ka psoriasis plaque waena a koʻikoʻi i nā pākeke. ʻO ia hoʻi, ua kauoha ʻia i ka wā e uhi ai kāu psoriasis i kahi ʻāpana nui o kou kino a i ʻole e hoʻopilikia nui i kou ola.

Hiki i kāu kauka ke ʻōlelo aku iā tildrakizumab inā loaʻa iā ʻoe ka psoriasis i pane ʻole i nā lāʻau lapaʻau topical e like me nā ʻaila a me nā hamo. He koho nō hoʻi inā he moho ʻoe no ka lāʻau lapaʻau systemic, ʻo ia hoʻi nā lāʻau lapaʻau e hana ana ma kou kino holoʻokoʻa ma mua o ka ʻili wale nō.

Hoʻolālā ʻia ka lāʻau lapaʻau no ka psoriasis plaque, ʻo ia ke ʻano maʻamau o ka psoriasis. Hoʻokumu kēia ʻano i nā pā i hāpai ʻia, ʻulaʻula i uhi ʻia me nā unahi kālā e hiki ke ʻike ʻia ma nā wahi a pau o kou kino akā pili pinepine i kou mau kuʻekuʻe, nā kuli, ke poʻo, a me ke kua haʻahaʻa.

Pehea e hana ai ʻo Tildrakizumab?

Hana ʻo Tildrakizumab ma ka pale ʻana i kahi protein kikoʻī i kapa ʻia ʻo interleukin-23 (IL-23) i loko o kāu ʻōnaehana pale. He kuleana nui kēia protein i ka hoʻoulu ʻana i ka mumū a me ka ulu wikiwiki ʻana o nā cell skin e hōʻike ana i ka psoriasis.

E noʻonoʻo iā IL-23 ma ke ʻano he ʻelele e haʻi ana i kāu ʻōnaehana pale e hana i ka mumū i kou ʻili. Ma ka pale ʻana i kēia ʻelele, kōkua ʻo tildrakizumab i ka hōʻemi ʻana i ka pane pale nui e alakaʻi ai i nā hōʻailona psoriasis.

Manaʻo ʻia kēia lāʻau lapaʻau he ikaika iki ma waena o nā lāʻau lapaʻau psoriasis. Ua ʻoi aku ka nui o ka pahuhopu ma mua o kekahi mau lāʻau lapaʻau systemic kahiko, ʻo ia hoʻi he liʻiliʻi nā hopena i kāu ʻōnaehana pale holoʻokoʻa ʻoiai e pono ana no nā hōʻailona psoriasis.

Kōkua ka hana pale i ka hoʻolohi ʻana i ka hoʻololi wikiwiki ʻana o nā cell skin e hana ana i kēlā mau pā mānoanoa a unahi. I ka hala ʻana o ka manawa, hiki i kēia ke alakaʻi i ka ʻili maʻemaʻe a me ka hōʻemi ʻana i ka mumū ma nā wahi i hoʻopilikia ʻia.

Pehea wau e lawe ai iā Tildrakizumab?

Hāʻawi ʻia ʻo Tildrakizumab ma ke ʻano he injection ma lalo o kou ʻili, maʻamau i kou ʻūhā, ka ʻōpū, a i ʻole ka lima luna. E aʻo kāu mea mālama ola iā ʻoe pehea e hoʻokomo ai iā ʻoe iho, a i ʻole hiki iā ʻoe ke hana ma ke keʻena lapaʻau.

Hele mai ka lāʻau lapaʻau i loko o kahi mea hoʻopiha mua ʻia a i ʻole ka mea peni e maʻalahi ai ka hoʻokomo ʻana iā ʻoe iho. Pono ʻoe e ʻae i ka lāʻau lapaʻau e hiki i ka mahana o ka lumi ma mua o ka hoʻokomo ʻana, kahi e lawe ai ma kahi o 30 mau minuke ma hope o ka wehe ʻana mai ka pahu hau.

Hiki iā ʻoe ke lawe i ka tildrakizumab me ka ʻole o ka meaʻai no ka mea ua hoʻokomo ʻia ma mua o ka lawe ʻia ʻana e ka waha. Eia naʻe, pono ʻoe e hoʻololi i nā wahi injection e pale ai i ka huhū o ka ʻili a pale i ka hoʻokomo ʻana i nā wahi kahi e palupalu ai kou ʻili, ʻeha, a i ʻole i hoʻopilikia ʻia e ka psoriasis.

Ma mua o kēlā me kēia injection, e hoʻomaʻemaʻe pono i kou mau lima a hoʻomaʻemaʻe i ka pūnaewele injection me kahi swab waiʻona. E hōʻoia e hoʻolei palekana i nā nila a me nā syringes i hoʻohana ʻia i loko o kahi pahu ʻoi.

Pehea ka lōʻihi e lawe ai au i ka Tildrakizumab?

Hoʻomaka ka hapa nui o nā kānaka me kahi mahele mua, a ukali ʻia e kekahi mahele ʻē aʻe 4 mau pule ma hope, a laila e hoʻomau me nā mahele i kēlā me kēia 12 pule. E hoʻoholo kāu kauka i ka papa manawa kūpono no kāu kūlana.

He maʻi maʻi ka Psoriasis, ʻo ia hoʻi ʻo tildrakizumab kahi lapaʻau lōʻihi. Nui ka poʻe e hoʻomau ana i ka lawe ʻana iā ia no nā mahina a i ʻole nā ​​makahiki e mālama i ka ʻili maʻemaʻe a pale i nā hōʻailona psoriasis mai ka hoʻi ʻana.

Hiki iā ʻoe ke hoʻomaka e ʻike i nā hoʻomaikaʻi ʻana i kou ʻili i loko o nā pule mua, akā hiki ke lawe i 12-16 mau pule e ʻike i nā hopena piha. E nānā kāu kauka i kāu holomua a hiki ke hoʻololi i kāu hoʻolālā lapaʻau e pili ana i ka maikaʻi o kāu pane.

Mai hooki i ka lawe ʻana i ka tildrakizumab me ka ʻole e kamaʻilio mua me kāu kauka. ʻO ka hoʻōki ʻana i ka hikiwawe hiki ke hoʻihoʻi a hōʻino paha i kāu mau hōʻailona psoriasis.

He aha nā hopena ʻaoʻao o Tildrakizumab?

E like me nā lāʻau lapaʻau a pau, hiki i ka tildrakizumab ke hoʻoulu i nā hopena ʻaoʻao, ʻoiai ʻaʻole i loaʻa i nā mea a pau. ʻO ka hapa nui o nā hopena ʻaoʻao he maʻalahi a hiki ke mālama ʻia me ka nānā pono.

Eia nā hopena ʻaoʻao maʻamau e hiki iā ʻoe ke ʻike:

• Nā maʻi o ka ʻōnaehana hanu luna e like me ke anu a i ʻole nā maʻi sinus
• Nā hopena ma ke kahua o ka pahu, e like me ka ʻulaʻula, ka pehu, a i ʻole ka ʻeha māmā
• Ka maʻi palahī a i ʻole ka ʻoluʻolu o ka ʻōpū
• Ka ʻeha o ke kua a i ʻole nā ʻeha ʻiʻo
• Nā poʻo

Hoʻomaikaʻi maʻamau kēia mau hopena ʻaoʻao i ka wā e hoʻoponopono ai kou kino i ka lāʻau, a hiki i ka hapa nui o nā kānaka ke hoʻomau i kā lākou lapaʻau me ka ʻole o ka hoʻopau ʻana.

Pono kekahi mau hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi i ka mālama olakino koke:

• Nā hōʻailona o ka maʻi koʻikoʻi e like me ke kuni, nā anu, a i ʻole ka ʻūlū mau
• Ka luhi a i ʻole ka nāwaliwali ʻole
• Nā hopena maʻi maʻi koʻikoʻi me ka pilikia o ka hanu a i ʻole ka pehu
• Nā hōʻailona maʻi ʻōpū mumū hou a i ʻole e ʻinoʻino ana
• Nā hopena ʻili ma waho o ke kahua o ka pahu

Hiki i nā hopena ʻaoʻao laha akā koʻikoʻi ke komo i ka piʻi ʻana o ka pilikia o kekahi mau maʻi a i ʻole nā hopena hiki ke hana i kāu hana ate. E nānā mau kāu kauka iā ʻoe me nā hoʻokolohua koko e hopu koke i nā pilikia.

ʻO wai ka mea pono ʻole e lawe iā Tildrakizumab?

ʻAʻole kūpono ʻo Tildrakizumab no nā mea a pau, a ʻo kekahi mau maʻi olakino a i ʻole nā kūlana e kūpono ʻole ai a i ʻole e koi ai i nā hana kūikawā.

ʻAʻole pono ʻoe e lawe iā tildrakizumab inā he maʻi koʻikoʻi ikaika kou ma nā wahi a pau o kou kino. Aia kēia i nā maʻi bacteria, viral, fungal, a i ʻole parasitic i mālama ʻole ʻia a hoʻoponopono ʻia.

Pono ka poʻe me kekahi mau maʻi olakino i ka loiloi akahele ma mua o ka hoʻomaka ʻana iā tildrakizumab:

• Mōʻaukala o nā maʻi hou a i ʻole nā kūlana e hoʻonui ai i ka pilikia o ka maʻi
• Maʻi ʻōpū mumū e like me ka maʻi o Crohn a i ʻole ka ulcerative colitis
• Nā lāʻau lapaʻau hou me nā lāʻau lapaʻau ola
• Tuberculosis a i ʻole ka hōʻike ʻana i ka tuberculosis
• Nā maʻi Hepatitis B a i ʻole C

Pono kāu kauka e loiloi pono i kēia mau kūlana no ka mea e pili ana ʻo tildrakizumab i kāu ʻōnaehana pale a hiki ke hoʻonui i kekahi mau pilikia olakino.

Pono ka mālama kūikawā i ka wā hāpai a me ka hānai ʻana i ka waiū. ʻOiai he palena nā ʻikepili e pili ana i ka palekana o tildrakizumab i ka wā hāpai, pono ʻoe e kūkākūkā i nā pilikia a me nā pōmaikaʻi me kāu kauka inā hāpai ʻoe, e hoʻolālā ana e hāpai, a i ʻole e hānai ana i ka waiū.

Inoa Brand Tildrakizumab

ʻO ka inoa brand no tildrakizumab ʻo Ilumya. ʻO kēia ka inoa āu e ʻike ai ma kāu ʻōmole kauoha a me ka ʻeke lāʻau.

Hana ʻia ʻo Ilumya e Sun Pharmaceutical Industries a ua ʻae ʻia e ka FDA i ka makahiki 2018 no ka mālama ʻana i ka psoriasis plaque maʻamau a koʻikoʻi i nā pākeke. ʻO ia wale nō ka mana inoa brand o tildrakizumab i loaʻa i kēia manawa.

Ke kamaʻilio ʻana me kāu kauka a i ʻole ka lāʻau lapaʻau, hiki iā ʻoe ke kuhikuhi i kāu lāʻau lapaʻau ma ke ʻano he tildrakizumab a i ʻole Ilumya - he lāʻau lapaʻau like lākou. Hiki i kāu ʻinikua a me ka lāʻau lapaʻau ke hoʻohana i kekahi inoa i ka wā e hana ana i kāu kauoha.

Nā Koho ʻē aʻe o Tildrakizumab

Nui nā lāʻau lapaʻau olaola ʻē aʻe e hana like me tildrakizumab no ka mālama ʻana i ka psoriasis. Hoʻopā kēia mau koho ʻē aʻe i nā protein like ʻole i loko o ka ʻōnaehana pale akā manaʻo e hoʻokō i nā hopena like.

ʻO nā mea pale IL-23 ʻē aʻe e like me tildrakizumab me guselkumab (Tremfya) a me risankizumab (Skyrizi). Hana kēia mau lāʻau lapaʻau ma ke ala like a loaʻa nā hopena like a me nā ʻaoʻao.

Hoʻopā nā koho olaola hou i nā ala ʻōnaehana pale like ʻole:

• Nā mea pale IL-17 e like me secukinumab (Cosentyx) a me ixekizumab (Taltz)
• Nā mea pale TNF e like me adalimumab (Humira) a me etanercept (Enbrel)
• Nā mea pale IL-12/23 e like me ustekinumab (Stelara)

E kōkua kāu kauka iā ʻoe e koho i ke koho maikaʻi loa e pili ana i kāu kūlana kikoʻī, ka mōʻaukala olakino, a me ke ʻano o kāu pane ʻana i nā lāʻau lapaʻau ma mua. Loaʻa i kēlā me kēia lāʻau lapaʻau kāna papa hana, ka hopena ʻaoʻao, a me nā mea e noʻonoʻo ai.

Ua ʻoi aku ka maikaʻi o Tildrakizumab ma mua o Adalimumab?

He mea pono ʻo Tildrakizumab a me Adalimumab no ka mālama ʻana i ka psoriasis, akā hana lākou ma nā ʻano like ʻole a loaʻa nā pono like ʻole. ʻO ke koho "maikaʻi" e hilinaʻi ana i kāu mau pono pilikino a me ke kūlana olakino.

Hoʻopā ʻo Tildrakizumab i ka IL-23, aʻo Adalimumab e ālai i ka TNF-alpha. Hōʻike nā haʻawina lapaʻau e hiki ke ʻoi aku ka maikaʻi o Tildrakizumab no ka loaʻa ʻana o ka ʻili maʻemaʻe a kokoke paha i ka maʻemaʻe i kekahi poʻe, ʻo ia hoʻi ka poʻe me ka psoriasis waena a koʻikoʻi.

He ʻokoʻa nui nā papa hana lāʻau ma waena o kēia mau lāʻau. Hāʻawi ʻia ʻo Tildrakizumab i kēlā me kēia 12 pule ma hope o nā lāʻau mua, aʻo Adalimumab e koi pinepine i nā injections i kēlā me kēia pule ʻē aʻe. Hiki i kēia lāʻau liʻiliʻi me Tildrakizumab ke ʻoluʻolu i kekahi poʻe.

He ʻokoʻa nō hoʻi nā ʻaoʻao hopena ma waena o nā lāʻau ʻelua. Ua loaʻa ʻo Adalimumab no ka manawa lōʻihi a loaʻa nā ʻikepili honua maoli, aʻo Tildrakizumab he mea hou me ka liʻiliʻi o nā pilina lāʻau a me nā hopena i ka ʻōnaehana pale ākea.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Tildrakizumab

He Palekana ʻo Tildrakizumab no ka poʻe me ka maʻi diabetes?

Hiki ke hoʻohana palekana ʻia ʻo Tildrakizumab i ka poʻe me ka maʻi diabetes, akā pono kāu kauka e nānā pono iā ʻoe. Hiki i ka poʻe me ka maʻi diabetes ke loaʻa i ka pilikia kiʻekiʻe o nā maʻi, a hiki nō hoʻi iā Tildrakizumab ke hoʻopilikia i ka hiki o kou ʻōnaehana pale e hakakā i nā maʻi.

Makemake paha kāu kauka e hōʻoia i ka maikaʻi o kāu maʻi diabetes ma mua o ka hoʻomaka ʻana iā Tildrakizumab. Hiki iā lākou ke ʻōlelo aku i nā nānā pinepine e nānā i nā hōʻailona o ka maʻi a i ʻole nā pilikia ʻē aʻe.

He aha kaʻu e hana ai inā hoʻohana hewa au i ka nui o Tildrakizumab?

Inā ʻoe e hoʻokomo hewa i ka nui o Tildrakizumab ma mua o ka mea i kauoha ʻia, e hoʻokaʻaʻike koke i kāu kauka a i ʻole ke kauka lapaʻau. ʻOiai he kakaikahi nā overdoses me Tildrakizumab ma muli o kāna hoʻolālā syringe i hoʻopiha mua ʻia, he mea nui e kiʻi i ka ʻōlelo aʻo lapaʻau.

Mai hoʻāʻo e uku ma ka lele ʻana i kāu mahele lāʻau e hiki mai ana a i ʻole ka hoʻololi ʻana i kāu papa hana ma kāu iho. E hāʻawi kāu kauka i ke alakaʻi i ke ʻano e hoʻomau ai me ka palekana a makemake paha e nānā pono iā ʻoe no nā hopena ʻaoʻao.

He aha kaʻu e hana ai inā ua hala wau i kahi mahele lāʻau o Tildrakizumab?

Inā ua hala ʻoe i kahi mahele lāʻau i hoʻonohonoho ʻia o tildrakizumab, e lawe koke iā ia ke hoʻomanaʻo ʻoe. A laila e hoʻomau me kāu papa hana maʻamau mai ia manawa aku.

Mai pāpālua i nā mahele lāʻau a i ʻole e hoʻāʻo e hana i ka mahele lāʻau i hala ma ka lawe ʻana i ka lāʻau hou. E kelepona i ke keʻena o kāu kauka inā ʻaʻole ʻoe maopopo e pili ana i ka manawa a i ʻole inā ua hala ʻoe i nā mahele lāʻau he nui, no ka mea, pono paha lākou e hoʻoponopono i kāu papa hana lapaʻau.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Tildrakizumab?

Pono ʻoe e hooki i ka lawe ʻana iā tildrakizumab ma lalo o ke alakaʻi a kāu kauka. No ka mea, he maʻi maʻi ka psoriasis, ʻo ka hooki ʻana i ka lāʻau lapaʻau e hoʻihoʻi mai i kāu mau hōʻailona i ka manawa.

Hiki i kāu kauka ke ʻōlelo e hooki i ka tildrakizumab inā loaʻa iā ʻoe nā hopena ʻaoʻao koʻikoʻi, loaʻa nā maʻi, a i ʻole inā ua mālama maikaʻi ʻia kāu psoriasis no ka manawa lōʻihi. E hana pū lākou me ʻoe e hoʻomohala i kahi hoʻolālā no ka nānā ʻana i kou kūlana ma hope o ka hooki ʻana i ka lāʻau lapaʻau.

Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Tildrakizumab?

Hiki iā ʻoe ke loaʻa ka hapa nui o nā lāʻau lapaʻau i ka wā e lawe ana iā tildrakizumab, akā pono ʻoe e pale i nā lāʻau lapaʻau ola. E ʻōlelo kāu kauka e kiʻi i nā lāʻau lapaʻau pono a pau ma mua o ka hoʻomaka ʻana i ka lapaʻau inā hiki.

ʻO nā lāʻau lapaʻau maʻamau e like me ka pana flu, nā lāʻau lapaʻau COVID-19, a me nā lāʻau lapaʻau ʻē aʻe i hoʻopau ʻia, palekana ke loaʻa i ka wā e lawe ana iā tildrakizumab. Eia naʻe, e hōʻike mau i kāu mea mālama ola e lawe ana ʻoe i kēia lāʻau lapaʻau ma mua o ka loaʻa ʻana o kekahi lāʻau lapaʻau.